The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis

Introduction: Alpha-1 antitrypsin (AAT) is a glycoprotein produced by liver, belonging to the serine protease inhibitor family. Alpha-1 antitrypsin deficiency (AATD) is very common autosomal recessive genetic disease caused by point mutation in SERPINA1 gene. Mutations in the alpha-1 antitrypsin...

Full description

Bibliographic Details
Main Authors: Dawid Kościołek, Michał Urbaś, Martyna Kępczyk, Aleksandra Kościołek, Kaja Surowiecka, Jakub Misiak, Miłosz Ojdana, Konrad Szalbot, Mikołaj Tokarski, Natalia Marczak
Format: Article
Language:English
Published: Kazimierz Wielki University 2024-02-01
Series:Journal of Education, Health and Sport
Subjects:
Online Access:https://apcz.umk.pl/JEHS/article/view/48340
_version_ 1797300994759983104
author Dawid Kościołek
Michał Urbaś
Martyna Kępczyk
Aleksandra Kościołek
Kaja Surowiecka
Jakub Misiak
Miłosz Ojdana
Konrad Szalbot
Mikołaj Tokarski
Natalia Marczak
author_facet Dawid Kościołek
Michał Urbaś
Martyna Kępczyk
Aleksandra Kościołek
Kaja Surowiecka
Jakub Misiak
Miłosz Ojdana
Konrad Szalbot
Mikołaj Tokarski
Natalia Marczak
author_sort Dawid Kościołek
collection DOAJ
description Introduction: Alpha-1 antitrypsin (AAT) is a glycoprotein produced by liver, belonging to the serine protease inhibitor family. Alpha-1 antitrypsin deficiency (AATD) is very common autosomal recessive genetic disease caused by point mutation in SERPINA1 gene. Mutations in the alpha-1 antitrypsin gene lead to production of misfolded AAT resulting in impaired release into the blood. This disorder leads to destruction of connecting tissue especially in lungs and to accumulation of retarded protein in the liver.  Purpose: Most studies addressing AAT deficiency focus on presenting symptoms related to the lungs and liver. We want to take a broader look at this issue, so we have closely examined scientific reports on the presentation of the disease in organs other than the lungs and liver. The goal is to gather holistic knowledge about the disease to enhance awareness and treatment.   Material and methods:    In our paper, we endeavored to address the issue of AAT deficiency comprehensively. We explored symptoms with an emphasis on organs beyond the liver and lungs. We also delved into the etiology, diagnosis, treatment, and prognosis of this disease.   Discussion:   The clinical symptoms of alpha 1 antitrypsin deficiency extending beyond the liver and lungs remain inadequately described. We know that AAT deficiency can lead to excessive destruction of connective tissue in any organ, not just the lungs and liver. Unfortunately, this condition continues to go undiagnosed, and the number of scientific publications on symptoms from other organs is too limited. This affects the insufficient attention given by doctors to tissue destruction in organs other than the lungs and liver.
first_indexed 2024-03-07T23:15:57Z
format Article
id doaj.art-677bf7bd90444c57aa87695516184974
institution Directory Open Access Journal
issn 2391-8306
language English
last_indexed 2024-03-07T23:15:57Z
publishDate 2024-02-01
publisher Kazimierz Wielki University
record_format Article
series Journal of Education, Health and Sport
spelling doaj.art-677bf7bd90444c57aa876955161849742024-02-21T11:52:50ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062024-02-016110.12775/JEHS.2024.61.013The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosisDawid Kościołek0Michał Urbaś1Martyna Kępczyk2Aleksandra Kościołek3Kaja Surowiecka4Jakub Misiak5Miłosz Ojdana6Konrad Szalbot7Mikołaj Tokarski8Natalia Marczak9Medical University of LodzStefan Zeromski Specialist HospitalMedical University of LodzMedical University of LodzStudent Research Club of Orthopedics and Traumatology, Medical University of LublinDepartment of Pathology, Chair of Oncology, Medical University of LodzMilitary Medical Academy Memorial Teaching Hospital – Central Veterans’ HospitalMedical University of LodzMedical University of LodzPoznan University of Medical Sciences Collegium Maius Introduction: Alpha-1 antitrypsin (AAT) is a glycoprotein produced by liver, belonging to the serine protease inhibitor family. Alpha-1 antitrypsin deficiency (AATD) is very common autosomal recessive genetic disease caused by point mutation in SERPINA1 gene. Mutations in the alpha-1 antitrypsin gene lead to production of misfolded AAT resulting in impaired release into the blood. This disorder leads to destruction of connecting tissue especially in lungs and to accumulation of retarded protein in the liver.  Purpose: Most studies addressing AAT deficiency focus on presenting symptoms related to the lungs and liver. We want to take a broader look at this issue, so we have closely examined scientific reports on the presentation of the disease in organs other than the lungs and liver. The goal is to gather holistic knowledge about the disease to enhance awareness and treatment.   Material and methods:    In our paper, we endeavored to address the issue of AAT deficiency comprehensively. We explored symptoms with an emphasis on organs beyond the liver and lungs. We also delved into the etiology, diagnosis, treatment, and prognosis of this disease.   Discussion:   The clinical symptoms of alpha 1 antitrypsin deficiency extending beyond the liver and lungs remain inadequately described. We know that AAT deficiency can lead to excessive destruction of connective tissue in any organ, not just the lungs and liver. Unfortunately, this condition continues to go undiagnosed, and the number of scientific publications on symptoms from other organs is too limited. This affects the insufficient attention given by doctors to tissue destruction in organs other than the lungs and liver. https://apcz.umk.pl/JEHS/article/view/48340alpha1-antitrypsinalpha-1-antitrypsine deficiencyCOPDcirrhosis
spellingShingle Dawid Kościołek
Michał Urbaś
Martyna Kępczyk
Aleksandra Kościołek
Kaja Surowiecka
Jakub Misiak
Miłosz Ojdana
Konrad Szalbot
Mikołaj Tokarski
Natalia Marczak
The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis
Journal of Education, Health and Sport
alpha1-antitrypsin
alpha-1-antitrypsine deficiency
COPD
cirrhosis
title The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis
title_full The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis
title_fullStr The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis
title_full_unstemmed The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis
title_short The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis
title_sort alpha 1 antitrypsin deficiency etiology symptoms in various organs diagnosis treatment prognosis
topic alpha1-antitrypsin
alpha-1-antitrypsine deficiency
COPD
cirrhosis
url https://apcz.umk.pl/JEHS/article/view/48340
work_keys_str_mv AT dawidkosciołek thealpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT michałurbas thealpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT martynakepczyk thealpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT aleksandrakosciołek thealpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT kajasurowiecka thealpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT jakubmisiak thealpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT miłoszojdana thealpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT konradszalbot thealpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT mikołajtokarski thealpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT nataliamarczak thealpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT dawidkosciołek alpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT michałurbas alpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT martynakepczyk alpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT aleksandrakosciołek alpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT kajasurowiecka alpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT jakubmisiak alpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT miłoszojdana alpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT konradszalbot alpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT mikołajtokarski alpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis
AT nataliamarczak alpha1antitrypsindeficiencyetiologysymptomsinvariousorgansdiagnosistreatmentprognosis